. 2020 Oct 13;31(1):8–16. doi: 10.1016/j.tcm.2020.10.001

Table 3.

Role of imaging techniques in differential diagnosis of various cardiovascular complications in patients with COVID-19.

Clinical scenario		Imaging modalities
		TTE	CT	CMR	ICA
Suspected ACS	STE	+	-	-	++
Suspected ACS	non-STE	++	++^*^/^⁎⁎	-	+
Suspected myocarditis		++	+^⁎⁎	++	-
Suspected pericarditis		++	+	+	-
Suspected decompensated chronic heart failure		++	-	-	-
Suspected PE		+	++^⁎⁎⁎	-	-
Suspected TTS		++	+^*	++	+

ACS, acute coronary syndrome; CMR, cardiac magnetic resonance; CT, computed tomography; ICA, invasive coronary angiography; PE, pulmonary embolism; STE, ST-segment elevation; TTE, transthoracic echocardiography; TTS, takotsubo syndrome.

ACS, acute coronary syndrome; PE, pulmonary embolism; STE, ST-segment elevation; TTE, transthoracic echocardiography; TTS, takotsubo syndrome.

Modified from Cosyns B et al. Eur Heart J Cardiovasc Imaging 2020;21:709-714.

^⁎

CCTA should be performed to rule in/out coronary artery disease and schedule subsequent invasive coronary angiography;

^⁎⁎

CT with late iodine enhancement may be useful to detect areas of myocardial fibrosis;

^⁎⁎⁎

CTPA is the gold standard for the assessment of pulmonary artery thrombi.